Literature DB >> 10973657

Mitochondrial DNA heteroplasmy after human ooplasmic transplantation.

C A Brenner1, J A Barritt, S Willadsen, J Cohen.   

Abstract

OBJECTIVE: To determine the patterns of mitochondrial inheritance in embryos, fetuses, and infants after ooplasmic transplantation using the technique of mitochondrial DNA (mtDNA) fingerprinting.
DESIGN: Prospective clinical study.
SETTING: The IVF program at Saint Barnabas Medical Center, a nonprofit community hospital. PATIENT(S): In a total of 23 cases with recurrent implantation failure after IVF ooplasmic transplantation was performed. Thirteen embryos from two patients and amniotic cells from four patients were investigated for heteroplasmy. Placenta and fetal cord blood cells from four newborn babies/infants were also investigated. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): mtDNA fingerprinting, polymerase chain reaction, and DNA sequencing analysis. RESULT(S): In addition to the recipient maternal mitochondrial DNA, a small proportion of donor mitochondrial DNA was detected in samples with the following frequencies: embryos (n = 6/13), amniocytes (n = 1/4), placenta (n = 2/4), and fetal cord blood (n = 2/4). Fingerprinting showed that nuclear DNA was not inherited from the donor in placenta or fetal cord blood of the babies. CONCLUSION(S): Ooplasmic transfer can result in sustained mtDNA heteroplasmy representing both donor and recipient. This was shown by mtDNA fingerprinting of embryos, amniocytes, fetal placenta, and cord blood. These results show that the donor-derived mitochondrial population persists after ooplasmic transfer and may be replicated during fetal development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973657     DOI: 10.1016/s0015-0282(00)00681-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

Review 1.  The next (re)generation of ovarian biology and fertility in women: is current science tomorrow's practice?

Authors:  Dori C Woods; Jonathan L Tilly
Journal:  Fertil Steril       Date:  2012-06-06       Impact factor: 7.329

Review 2.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

3.  Evaluation of the meiotic spindle apparatus in metaphase II human oocytes following cytoplasmic donation.

Authors:  E L Jones; C A Boyd; D Dowling-Lacey; D Wright; J F Mayer; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

Review 4.  Investigating human disease using stem cell models.

Authors:  Jared L Sterneckert; Peter Reinhardt; Hans R Schöler
Journal:  Nat Rev Genet       Date:  2014-07-29       Impact factor: 53.242

Review 5.  Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies.

Authors:  Hideki Igarashi; Toshifumi Takahashi; Satoru Nagase
Journal:  Reprod Med Biol       Date:  2015-05-09

Review 6.  Would gene therapy for the treatment of male infertility be safe?

Authors:  Dolores J Lamb
Journal:  Nat Clin Pract Urol       Date:  2008-10-14

Review 7.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

Review 8.  Autologous Germline Mitochondrial Energy Transfer (AUGMENT) in Human Assisted Reproduction.

Authors:  Dori C Woods; Jonathan L Tilly
Journal:  Semin Reprod Med       Date:  2015-11-17       Impact factor: 1.303

9.  Paternal mitochondrial DNA transmission during nonhuman primate nuclear transfer.

Authors:  Justin C St John; Gerald Schatten
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

10.  Mitochondrial gene replacement in primate offspring and embryonic stem cells.

Authors:  Masahito Tachibana; Michelle Sparman; Hathaitip Sritanaudomchai; Hong Ma; Lisa Clepper; Joy Woodward; Ying Li; Cathy Ramsey; Olena Kolotushkina; Shoukhrat Mitalipov
Journal:  Nature       Date:  2009-08-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.